Highlights

  1. Home
  2. Highlights

Announcing Kickoff of Clinical Study for First-of-its-kind Device-drug Combination Product

February 2, 2025 – Regenity Biosciences announced the enrollment of the first…

Read More

Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation

Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…

Read More

Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care

PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…

Read More

Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study

Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…

Read More

GUIDOR Portfolio

Click this link to learn about Guidor, our synthetic bone grafting system.

Read More

Natsuyo Lee Reflects on 20 Years at Regenity

Natsuyo Lee (Nat) plays a pivotal role in bringing innovation to life at Regenity Biosciences….

Read More

Let’s Connect

Looking for a reliable partner to fill your product portfolio gap, co-create your next great innovation or manufacture your products?
Let’s Connect